Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19Christopher D. Barrett, Michael B. Yaffe, Hunter B. Moore et al.|CHEST Journal|2021Cited by 53
Respiratory drive heterogeneity associated with systemic inflammation and vascular permeability in acute respiratory distress syndromeElias Baedorf-Kassis, Edgar Jiménez, Michael Murn et al.|Critical Care|2024Cited by 16
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort studyChristopher D. Barrett, Michael B. Yaffe, Hunter B. Moore et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 9
Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trialLaurent Renard Triché, Joris Pensier, Boris Jung et al.|Anaesthesia Critical Care & Pain Medicine|2025Cited by 9
Response to: The (Mechanical) Power of (Automated) VentilationElias Baedorf-Kassis, Daniel Talmor, Andres Brenes Bastos et al.|Respiratory Care|2023Cited by 0